Rhythm Biosciences is an innovative Australian, publicly listed medical diagnostics company, with a focus on delivering simple, affordable blood tests for the accurate detection of cancers, providing physicians with accurate and reliable diagnostic tools.
Early detection is critical to improving patient outcomes and reducing the global burden of cancer.
ColoSTAT®, Rhythm Bioscience’s first simple blood-based cancer test, designed for the early detection of colorectal cancer, has been developed initially as an alternative screening test for individuals unable to or are unwilling to use currently available screening modalities.
Rhythm Biosciences is committed to working with likeminded global partners to achieve commercialisation and distribution of these simple solutions.
Company Details
- Employees
- 28
- Founded
- -
- Phone
- + 61 3 9614 0600
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- rhythmbio.com
- Keywords
- | ASX Company Secretary.
Rhythm Biosciences Limited Questions
Rhythm Biosciences Limited's helpline number is + 61 3 9614 0600
Rhythm Biosciences Limited's website is rhythmbio.com
Rhythm Biosciences Limited's LinkedIn profile is https://au.linkedin.com/company/rhythmbiosciences
Rhythm Biosciences Limited has
28 employees.
View email and phone details for 28
employees at Rhythm Biosciences Limited.
Rhythm Biosciences Limited's industry is
Biotechnology Research
Rhythm Biosciences Limited's top competitors are
Genetype,
Cell Therapies Pty Ltd,
Telix Pharmaceuticals Limited,
Imugene Limited,
Ternarx,
Haemalogix Ltd,
Carina Biotech,
Inoviq Ltd (Asx:iiq),
Gertrude Biomedical,
Prescient Therapeutics.
Rhythm Biosciences Limited's categories are Biotechnology Research
Rhythm Biosciences Limited's founding year is 2017
